Solid Tumors
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients aged 18-75 years, male and female unlimited; 2. Patients with ECoG score of 0 or 1; 3. Patients with high expression of ACE2 in colorectal cancer, renal cancer, pancreatic cancer, gastric cancer, liver cancer, lung cancer, brain tumor or suspected tumor who are to undergo pathological biopsy or tumor surgery in the near future (within 2 months); 4. Patients with 18F-FDG PET / CT results as baseline assessment.
Exclusion criteria
Exclusion criteria: 1. Patients with severe abnormal liver and kidney function; 2. Pregnant and lactating women during pregnancy preparation; 3. Patients who can't lie flat for half an hour; 4. Patients with claustrophobia or other mental diseases; 5. Patients who refused to join the clinical study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SUV;SEN, SPE, ACC, AUC of ROC; | — |
Countries
China
Contacts
Nuclear Medicine Department,Third floor, Outpatient Building, Beijing Cancer Hospital